Industry Discovery & Development Partnership Program
Breakthrough T1D's IDDP Program funds for-profit companies to develop innovative therapies or devices for type 1 diabetes, accelerating their path to commercialization and patient impact.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round by invitation or RFA)
Funding Amounts: As approved; requires 1:1 matching funds from the applicant company; award size and duration are negotiated per project.
Summary: Supports for-profit companies to accelerate discovery, development, and commercialization of T1D therapeutics or devices aligned with Breakthrough T1D’s strategic priorities.
Key Information: Applicants must commit at least equal matching funds and engage in a pre-application discussion with Breakthrough T1D staff.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D is designed to accelerate the translation of innovative research into impactful therapies and technologies for type 1 diabetes (T1D). The program specifically supports for-profit entities—such as biotechnology, pharmaceutical, and device companies—whose research projects align closely with Breakthrough T1D’s research strategy and priority areas. By leveraging the commercial expertise of industry partners and the scientific leadership of Breakthrough T1D, the IDDP aims to move promising therapies and devices toward commercialization and patient impact.
Projects must focus on the discovery and/or development of therapeutics or devices for the treatment, cure, or prevention of T1D. This mechanism is intended to foster long-term collaborations and bring products to key inflection points in development or regulatory approval.
